Can binimetinib, encorafenib and masitinib be more...

Can binimetinib, encorafenib and masitinib be more efficacious than currently available mutation-based targeted therapies for melanoma treatment?

Turner, Megan C, Rossfeld, Kara, Salama, April K.S, Tyler, Douglas, Beasley, Georgia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Expert Opinion on Pharmacotherapy
DOI:
10.1080/14656566.2017.1299710
Date:
March, 2017
File:
PDF, 717 KB
english, 2017
Conversion to is in progress
Conversion to is failed